Advanced Clinical Research Center of Fukushima Medical University: two cyclotrons installed facility for basic research and clinical application of medical radioisotopes
K. Takahashi, H. Tominaga, K. Washiyama, K. Nishijima, M. Aoki, S. Zhao, N. Ukon, N. Oriuchi
Advanced Clinical Research Center, Fukushima Medical University
Oral Presentation
The authors declare no conflicts of interest associated with this manuscript
The Advanced Research Clinical Center is a facili-ty established in June 2016 to restore Fukushima region from the disaster of the Fukushima Daiichi Nuclear Power Plant in 2011. This center manu-factures and various medical radioisotopes for cutting-edge diagnosis and treatment in Fuku-shima are. We have using two cyclotrons devel-oped by Sumitomo Heavy Industries, Ltd. The compact cyclotron MP-20S-V is mainly used for diagnostic RI production and clinical application. 11C, 13N, 15O and 18F are manufactured on a regu-lar basis and are used as clinical radiopharma-ceuticals such as 18FDG, 11C-PIB, 13NH3, 15O gas for patients. This cyclotron can also be used for research purposes and produces 64Cu, 89Zr, 124I and so on. The medium-sized cyclotron MP-30 is a new type of accelerator capable of accelerat-ing alpha beam up to 30 MeV. The MP-30 accel-erates three types of beams p, d, and a and is mainly used for research purposes. Up to now, 65Zn, 99mTc, 68Ge, 177Lu, and 211At have been pro-duced. As there is a need for using alpha emit-ters for tumor therapy, we are primarily focused on the manufacture of 211At for the application of target alpha therapy.